Five things for pharma marketers to know: Tuesday, January 23, 2018

FDA issues new policies for compounded drugs; U.S. doctors test CRISPR on cancer patients for the first time; Palio merged into GSW

New tactics change clinical trial awareness game

Recruitment for clinical trials has never been easy. New tools and tactics could change that — assuming the sheer volume of information doesn't overwhelm trial ...

Back to the Future: Print media thrives in point of care

Back to the Future: Print media thrives in point of care

Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care

Jennifer Gottlieb named W2O Group president

Jennifer Gottlieb named W2O Group president

She is overseeing three of the network's agencies in the newly created role.

Why Greater Than One's Elizabeth Apelles stands firm on independence

Why Greater Than One's Elizabeth Apelles stands firm on independence

The CEO of the independent healthcare agency discusses growing a business in digital in the early 2000s and the perks of remaining independent.

OPEN LENS

Interview | Patrick Richard, Syneos Health Communications

How can pharma brands actionize the data they are collecting? Larry Dobrow, MM&M senior editor, and Patrick Richard, EVP and managing director, data sciences, Syneos Health, weigh in on leveraging data and analytics in this video, sponsored by Syneos.

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Some microinfluencers see the latest YouTube guidelines as a "slap in the face."

Nick Law quits R/GA for lead creative role across Publicis Groupe

Nick Law quits R/GA for lead creative role across Publicis Groupe

Nick Law, the global chief creative officer of R/GA, is leaving the company after 17 years to take on the newly created role of chief creative officer across Publicis Groupe and president of Publicis Communications.

Five things for pharma marketers to know: Monday, January 22, 2018

Five things for pharma marketers to know: Monday, January 22, 2018

Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia

Google: slow mobile pages will hurt your ranking

Google: slow mobile pages will hurt your ranking

Advertisers have until July to get their mobile pages up to speed.

Five things for pharma marketers to know: Friday, January 19, 2018

Five things for pharma marketers to know: Friday, January 19, 2018

Biogen, UCB reportedly showing interest in Acorda acquisition; Kite Pharma and Pfizer to develop combo lymphoma therapy; hospitals to form generics nonprofit

Five things for pharma marketers to know: Thursday, January 18, 2018

Five things for pharma marketers to know: Thursday, January 18, 2018

Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution

YouTube announces measures to earn back trust from advertisers and agencies

YouTube announces measures to earn back trust from advertisers and agencies

In an effort to assure advertisers and agencies on brand safety, Google has announced two new requirements for video creators that intend to join the YouTube Partner Program.

Five things for pharma marketers to know: Wednesday, January 17, 2018

Five things for pharma marketers to know: Wednesday, January 17, 2018

Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer

Sandoz lines up potential third-to-market Humira copy

Sandoz lines up potential third-to-market Humira copy

Although if approved, it's not likely to launch in the U.S. for quite some time.

McCann Health promotes Marcus Sigurdsson to global chief digital officer

McCann Health promotes Marcus Sigurdsson to global chief digital officer

Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.

Five things for pharma marketers to know: Tuesday, January 16, 2018

Five things for pharma marketers to know: Tuesday, January 16, 2018

Merck's Keytruda combo therapy succeeds in Phase-III lung cancer trial; FDA launches pilot to address trial transparency; Spark's Luxturna overpriced, ICER says

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

New research calls into question the behavioral effects of some digital health tools.

What Facebook's news feed changes mean for brands and publishers

What Facebook's news feed changes mean for brands and publishers

Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.

Five things for pharma marketers to know: Friday, January 12, 2018

Five things for pharma marketers to know: Friday, January 12, 2018

Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

The founder of Stagwell has claimed digital marketing agencies are undervalued because investors still fail to appreciate how much digital communications and e-commerce are going to transform the economy.